Tag: Curis

. . Curis Inc. . undefined more than tripled Tuesday to lead all premarket gainers and with the largest volume after the biotech company announced. . .

. . Curis (CRIS) stock took off Tuesday after positive preliminary data from a Phase 1 clinical trial for the leukemia drug became known.

. . Curis, Inc. . (NASDAQ: CRIS) announced positive preclinical data from a Phse 1 clinic this morning on a possible cancer treatment, causing a stir. The data come from the Pha ...